ROMOSOZUMAB

romosozumab 105 mg/1.17 mL injection, 2 x 1.17 mL syringes

ROMOSOZUMAB (14641N)

romosozumab 105 mg/1.17 mL injection, 2 x 1.17 mL syringes
14641N
Body System:
Manner of administration:Injection
General Schedule
Authority Required

Restriction

Indication: Severe established osteoporosis
Treatment phase: Initial treatment - First-line therapy

Restriction

Indication: Severe established osteoporosis
Treatment phase: Continuing treatment - First-line therapy
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 2 # of repeats: 5 DPMQ: $406.46 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Evenity